Influence of Amino Acid Residue 374 of Cytochrome P-450 2D6 (CYP2D6) on the Regio- and Enantio-selective Metabolism of Metoprolol

Overview

Journal Biochem J

Specialty Biochemistry

Date 1996 Jun 1

PMID 8687412

Citations 8

Authors

S W Ellis

K Rowland

M J Ackland

E Rekka

A P Simula

M S Lennard

C R Wolf

G T Tucker

Affiliations

Soon will be listed here.

Abstract

Cytochrome P-450 2D6 (CYP2D6) is an important human drug-metabolizing enzyme responsible for the oxidation of more than 30 widely used therapeutic agents. The enzymes encoded by the published genomic [Kimura, Umeno, Skoda, Meyer and Gonzalez (1989) Am. J. Hum. Genet. 45, 889-904] and cDNA [Gonzalez, Skoda, Kimura, Umeno, Zanger, Nebert, Gelboin, Hardwick and Meyer (1988) Nature 331, 442-446] sequences of CYP2D6, and presumed to represent wild-type sequences, differ at residue 374 and encode valine (CYP2D6-Val) and methionine (CYP2D6-Met) respectively. The influence of this amino acid difference on cytochrome P-450 expression, ligand binding, catalysis and stereoselective oxidation of metoprolol was investigated by the heterologous expression of the corresponding cDNAs in the yeast Saccharomyces cerevisiae. The level of expression of apo- and holo-protein was similar with each form of CYP2D6 cDNA, and the binding affinities of a series of ligands to CYP2D6-Val and CYP2D6-Met were identical. The enantioselective O-demethylation and alpha-hydroxylation of metoprolol were also similar with each form of CYP2D6, O-demethylation being R-(+)- enantioselective (CYP2D6-Val: R/S, 1.6; CYP2D6-Met: R/S, 1.4), whereas alpha-hydroxylation showed a preference for S-(-)-metoprolol (CYP2D6-Val: R/S, 0.7; CYP2D6-Met: R/S, 0.8). However, although the favoured regiomer overall was O-demethylmetoprolol (ODM), the regioselectivity for O-demethylation of each metoprolol enantiomer was significantly greater for CYP2D6-Val [R-(+)-: ODM/alpha-hydroxymetoprolol (alpha OH), 5.9; S-(-)-: ODM/alpha OH, 2.5) than that observed for CYP2D6-Met [R-(+)-: ODM/alpha OH, 2.2; S-(-)-: ODM/alpha OH, 1.4]. The stereoselective properties of CYP2D6-Val were consistent with those observed for CYP2D6 in human liver microsomes. The difference in the stereoselective properties of CYP2D6-Val and CYP2D6-Met were rationalized with respect to a homology model of the active site of CYP2D6 based on an alignment with the crystal structure of the bacterial cytochrome P-450BM-3' CYP102.

Citing Articles

The Common Bean Gene Encodes Flavonoid 3'5' Hydroxylase: A Major Mutational Target for Flavonoid Diversity in Angiosperms.

McClean P, Lee R, Howe K, Osborne C, Grimwood J, Levy S Front Plant Sci. 2022; 13:869582.

PMID: 35432409 PMC: 9009181. DOI: 10.3389/fpls.2022.869582.

Conversion of amino acids to aryl/heteroaryl ethanol metabolites using human CYP2D6-expressing live baker's yeast.

Bhardwaj M, Chib S, Kaur L, Kumar A, Chaudhuri B, Malik F RSC Med Chem. 2021; 11(1):142-147.

PMID: 33479614 PMC: 7439282. DOI: 10.1039/c9md00451c.

Biotransformation, Using Recombinant CYP450-Expressing Baker's Yeast Cells, Identifies a Novel CYP2D6.10 Variant Which Is a Superior Metabolizer of Codeine to Morphine Than the Wild-Type Enzyme.

Williams I, Gatchie L, Bharate S, Chaudhuri B ACS Omega. 2019; 3(8):8903-8912.

PMID: 31459022 PMC: 6644518. DOI: 10.1021/acsomega.8b00809.

Crystal structure of human cytochrome P450 2D6 with prinomastat bound.

Wang A, Savas U, Hsu M, Stout C, Johnson E J Biol Chem. 2012; 287(14):10834-43.

PMID: 22308038 PMC: 3322812. DOI: 10.1074/jbc.M111.307918.

Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism.

Unwalla R, Cross J, Salaniwal S, Shilling A, Leung L, Kao J J Comput Aided Mol Des. 2010; 24(3):237-56.

PMID: 20361239 DOI: 10.1007/s10822-010-9336-6.

References

Ellis S, Ching M, Watson P, Henderson C, Simula A, Lennard M . Catalytic activities of human debrisoquine 4-hydroxylase cytochrome P450 (CYP2D6) expressed in yeast. Biochem Pharmacol. 1992; 44(4):617-20. DOI: 10.1016/0006-2952(92)90394-x. View

Ouzounis C, Melvin W . Primary and secondary structural patterns in eukaryotic cytochrome P-450 families correspond to structures of the helix-rich domain of Pseudomonas putida cytochrome P-450cam. Indications for a similar overall topology. Eur J Biochem. 1991; 198(2):307-15. DOI: 10.1111/j.1432-1033.1991.tb16017.x. View

Korzekwa K, Jones J . Predicting the cytochrome P450 mediated metabolism of xenobiotics. Pharmacogenetics. 1993; 3(1):1-18. DOI: 10.1097/00008571-199302000-00001. View

Ravichandran K, Boddupalli S, Hasermann C, Peterson J, Deisenhofer J . Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science. 1993; 261(5122):731-6. DOI: 10.1126/science.8342039. View

Koymans L, Vermeulen N, Baarslag A . A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building. J Comput Aided Mol Des. 1993; 7(3):281-9. DOI: 10.1007/BF00125503. View

Hasemann C, Ravichandran K, Peterson J, Deisenhofer J . Crystal structure and refinement of cytochrome P450terp at 2.3 A resolution. J Mol Biol. 1994; 236(4):1169-85. DOI: 10.1016/0022-2836(94)90019-1. View

Tucker G, Lennard M, Ellis S, Woods H, Cho A, Lin L . The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol. 1994; 47(7):1151-6. DOI: 10.1016/0006-2952(94)90386-7. View

Tucker G . Clinical implications of genetic polymorphism in drug metabolism. J Pharm Pharmacol. 1994; 46 Suppl 1:417-24. View

Saxena R, Shaw G, Relling M, Frame J, Moir D, Evans W . Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype. Hum Mol Genet. 1994; 3(6):923-6. DOI: 10.1093/hmg/3.6.923. View

10.

Williams M, Lennard M, Martin I, Tucker G . Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450. Carcinogenesis. 1994; 15(12):2733-8. DOI: 10.1093/carcin/15.12.2733. View

11.

Evert B, Griese E, Eichelbaum M . A missense mutation in exon 6 of the CYP2D6 gene leading to a histidine 324 to proline exchange is associated with the poor metabolizer phenotype of sparteine. Naunyn Schmiedebergs Arch Pharmacol. 1994; 350(4):434-9. DOI: 10.1007/BF00178963. View

12.

Hasemann C, Kurumbail R, Boddupalli S, Peterson J, Deisenhofer J . Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure. 1995; 3(1):41-62. DOI: 10.1016/s0969-2126(01)00134-4. View

13.

Poulos T . Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Nat Struct Biol. 1995; 2(2):144-53. DOI: 10.1038/nsb0295-144. View

14.

Mautz D, Nelson W, Shen D . Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6. Drug Metab Dispos. 1995; 23(4):513-7. View

15.

Lewis D . Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3). Xenobiotica. 1995; 25(4):333-66. DOI: 10.3109/00498259509061857. View

16.

Ellis S, Hayhurst G, Smith G, Lightfoot T, Wong M, Simula A . Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6. J Biol Chem. 1995; 270(49):29055-8. DOI: 10.1074/jbc.270.49.29055. View

17.

Omura T, Sato R . THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964; 239:2370-8. View

18.

Bernstein F, Koetzle T, Williams G, Meyer Jr E, Brice M, Rodgers J . The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol. 1977; 112(3):535-42. DOI: 10.1016/s0022-2836(77)80200-3. View

19.

Mahgoub A, Idle J, Dring L, Lancaster R, Smith R . Polymorphic hydroxylation of Debrisoquine in man. Lancet. 1977; 2(8038):584-6. DOI: 10.1016/s0140-6736(77)91430-1. View

20.

Tucker G, Silas J, Iyun A, Lennard M, Smith A . Polymorphic hydroxylation of debrisoquine. Lancet. 1977; 2(8040):718. DOI: 10.1016/s0140-6736(77)90527-x. View